50,00 €
HALO-MED (10 MG/120 TABLETS)
Each tablet contains:
Fluoxymesterone USР 10 mg.
Description:
When fluoxymesterone is indicated in proper doses for short periods and with appropriate diet to patients with cachexia or debilitating diseases, they may produce anabolic effects without clinical signs of virilism. The fluoxymesterone have been used in patients recovering from surgery, infections, burns, fractures, ameciating diseases and severe traumatic injuries.
| Active half-life (hours) | 62-70 hours |
| Group | Dopamine receptor agonists |
| Subgroup | Oral/tablet |
| Dosage | 0.25 mg/tablet |
| Application (men) | 0.50 mg per week |
| Product packaging | 10 tablets |
| Contents (active) | Cabergoline |
| Retains water | None |
| Flavoring | None |
| Anabolic activity | Low |
| Androgenic activity | Not existing |
| Water retention | No |
| Hypertension | Sometimes |
| Aromatization | No |
| Acne | No (in some cases it can also provide a degree of protection) |
| Activities | 16 Hours |
| Water retention | No |
| Classification | Steroid anabolic |
| Dosage | Men 30-80 mg/day |
| Hepatotoxicity | No |
| Acne | No |
| Flavoring | No |
| Activities | 9 Hours |
| Water retention | No |
| Classification | Steroid anabolic |
| Doses | Men 30-80 mg/day |
| Hepatotoxicity | Yes |
| Acne | Yes |
| Flavoring | No |
| Activity | 1 Day |
| Water retention | No |
| Classification | Hormone of thyroid |
| Dosage | Men 25-75 mcg/day |
| Hepatotoxicity | No |
| Acne | No |
| Flavoring | No |
| Active half-life (days) | 2-3 days |
| Group | Aromatase inhibitor |
| Subgroup | Oral/tablet |
| Dosage | 2.5 mg/tablet |
| Application (men) | 0.5-1 mg for 1-3 days |
| Product packaging | 30 tablets |
| Contents (active) | Letrozole |
| Retains water | No |
| Flavoring | No |
Reviews
There are no reviews yet.